| 000 | 01544 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250518052108.0 | ||
| 264 | 0 | _c20200825 | |
| 008 | 202008s 0 0 eng d | ||
| 022 | _a1477-092X | ||
| 024 | 7 |
_a10.1177/1078155219861679 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKucuk, Esra | |
| 245 | 0 | 0 |
_aDrug-related problems with targeted/immunotherapies at an oncology outpatient clinic. _h[electronic resource] |
| 260 |
_bJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners _cApr 2020 |
||
| 300 |
_a595-602 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aDrug-Related Side Effects and Adverse Reactions _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunotherapy _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMolecular Targeted Therapy _xadverse effects |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aOutpatient Clinics, Hospital |
| 650 | 0 | 4 | _aProspective Studies |
| 700 | 1 | _aBayraktar-Ekincioglu, Aygin | |
| 700 | 1 | _aErman, Mustafa | |
| 700 | 1 | _aKilickap, Saadettin | |
| 773 | 0 |
_tJournal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners _gvol. 26 _gno. 3 _gp. 595-602 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/1078155219861679 _zAvailable from publisher's website |
| 999 |
_c29937441 _d29937441 |
||